Michael Gelband’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-110,844
Closed -$29.1M 1877
2025
Q1
$29.1M Buy
+110,844
New +$30M 0.29% 57
2024
Q4
Sell
-56,070
Closed -$13.1M 1936
2024
Q3
$13.1M Buy
56,070
+35,709
+175% +$7.33M 0.08% 192
2024
Q2
$4.11M Buy
+20,361
New +$3.67M 0.03% 477
2024
Q1
Sell
-11,711
Closed -$2.54M 1866
2023
Q4
$2.54M Sell
11,711
-21,311
-65% -$3.66M 0.02% 510
2023
Q3
$5.27M Buy
33,022
+28,150
+578% +$6.3M 0.05% 361
2023
Q2
$1.41M Buy
+4,872
New +$1.48M 0.01% 961
2022
Q4
Sell
-6,432
Closed -$1.48M 2026
2022
Q3
$1.48M Buy
+6,432
New +$1.61M 0.02% 940
2022
Q2
Sell
-3,456
Closed -$921K 2336
2022
Q1
$921K Buy
3,456
+522
+18% +$128K 0.01% 1211
2021
Q4
$781K Buy
+2,934
New +$851K 0.01% 1197
2021
Q3
Sell
-20,614
Closed -$5.66M 2516
2021
Q2
$5.66M Sell
20,614
-1,673
-8% -$455K 0.06% 315
2021
Q1
$5.82M Sell
22,287
-17,930
-45% -$4.8M 0.08% 225
2020
Q4
$10.3M Buy
40,217
+7,265
+22% +$1.8M 0.1% 116
2020
Q3
$7.8M Buy
32,952
+6,959
+27% +$1.47M 0.16% 118
2020
Q2
$5.05M Buy
25,993
+9,961
+62% +$1.9M 0.13% 156
2020
Q1
$2.66M Buy
16,032
+13,832
+629% +$2.53M 0.15% 137
2019
Q4
$377K Sell
2,200
-46,498
-95% -$7.75M 0.01% 1015
2019
Q3
$8.03M Buy
48,698
+40,984
+531% +$5.76M 0.28% 74
2019
Q2
$921K Buy
7,714
+5,577
+261% +$572K 0.04% 273
2019
Q1
$203K Buy
+2,137
New +$183K 0.02% 563

Other funds holding PODD

Michael Gelband's PODD Position: Q2 2025 in Review

Michael Gelband sold out of Insulet (PODD) in Q2 2025, closing a stake of 110,844 shares — an estimated $29.1M sold.

Michael Gelband first reported a position in PODD in Q1 2019 and held it in 19 quarters. The position peaked at $29.1M in Q1 2025. 796 funds tracked by Wall St. Rank hold PODD as of Q2 2025.

  • Michael Gelband reported no remaining Insulet position as of Q2 2025 after selling out during the quarter.
  • Michael Gelband sold 110,844 Insulet shares in Q2 2025, an estimated $29.1M.
  • Michael Gelband first reported a position in Insulet in Q1 2019 and held it in 19 quarters.
  • Michael Gelband's Insulet position peaked at $29.1M in Q1 2025.
  • 796 funds tracked by Wall St. Rank held Insulet as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.